why choose us

First received: January 9, 2023

Clinical Trial: Cardio-protective Effect of Metformin in Patients Undergoing PCI

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Elective Percutaneous Coronary Intervention
Ischemic Reperfusion Injury

Study Type: Interventional


Official Title: Cardio-protective Effect of Metformin in Patients Undergoing Elective Percutaneous Coronary Intervention

Brief Summary: This is a two-arm randomized parallel study. Patients who will be meeting the above-mentioned criteria and agree to take part in the study, were asked to sign an informed consent prior conducting the study.The whole study protocol were presented to the local institutional review board (IRB).

Read more